Skip to main content

Advertisement

SpringerLink
Log in

Ketamine for Medically Refractory Status Epilepticus After Elective Aneurysm Clipping

  • Practical Pearl
  • Published:
Neurocritical Care Aims and scope Submit manuscript

Abstract

Background

Medically refractory status epilepticus, without an identifiable cause, post elective aneurysm clipping is a rare event.

Objective

To describe the two cases of refractory status epilepticus post elective aneurysm clipping, without an identifiable cause, and discuss the potential role for early consideration of ketamine.

Methods

Retrospectively reviewed two patients at our institution who developed refractory status epilepticus post elective aneurysm clipping, without a defined cause.

Results

Two patients who underwent elective aneurysm clipping developed medically refractory status epilepticus post-craniotomy. No structural, vascular, infectious, or metabolic cause was identified. Seizure control failed with multiple medications and intravenous sedatives over the period of weeks in both. Ketamine was instituted at 20 and 40 mg/kg/min in these patients. Within hours of starting ketamine, burst suppression was obtained in both.

Medications were all tapered over the next month, and both the patients recovered to be cognitively normal, with mild residual morbidity secondary to critical care polyneuropathy.

Conclusions

Refractory status epilepticus, in the absence of an identifiable etiology, in elective aneurysm clipping is a rare event. Consideration should be given for the early use of ketamine in refractory status epilepticus.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Al-Mefty O, Wrubel D, Haddad N. Postoperative nonconvulsive encephalopathic status: identification of a syndrome responsible for delayed progressive deterioration of neurological status after skull base surgery. J Neurosurg. 2009;111:1062–8.

    Article  PubMed  Google Scholar 

  2. Rabinowicz AL, Ginsburg DL, DeGiorgio CM, Gott PS, Giannotta SL. Unruptured intracranial aneurysms: seizures and antiepileptic drug treatment following surgery. J Neurosurg. 1991;75:371–3.

    Article  PubMed  CAS  Google Scholar 

  3. Lin CL, Dumont AS, Lieu AS, Yen CP, Hwang SL, Kwan AL, Kassell NF, Howng SL. Characterization of perioperative seizures and epilepsy following aneurismal subarachnoid hemorrhage. J Neurosurg. 2003;99:978–85.

    Article  PubMed  Google Scholar 

  4. Raper DMS, Kokabi N, McGee-Collett M. The efficacy of antiepileptic drug prophylaxis in the prevention of early and late seizures following repair of intracranial aneurysms. J Clin Neurosci. 2011;18:1174–9.

    Article  PubMed  CAS  Google Scholar 

  5. Wong JM, Ziewacz JE, Ho AL, Panchmatia JR, Kim AH, Bader AM, Thompson BG, Du R, Gawande AA. Patterns in neurosurgical adverse events; open cerebrovascular neurosurgery. Neurosurg Focus. 2012;33(5):E15.

    Article  PubMed  Google Scholar 

  6. Hoh BL, Nathoo S, Chi YY, Barker FG. Incidence of seizures of epilepsy after clipping or coiling of ruptured and unruptured cerebral aneurysms in the nationwide inpatient sample database: 2002–2007. Neurosurgery. 2011;69(3):644–50.

    Article  PubMed  Google Scholar 

  7. Voss LJ, Sleigh JW, Barnard JPM, Kirsch HE. The howling cortex: seizures and general anesthetic drugs. Anesth Analg. 2008;107(5):1689–703.

    Article  PubMed  Google Scholar 

  8. Recart A, Rawal S, White PF, Byerly S, Thornton L. The effect of remifentanil on seizure duration and acute hemodynamic responses to electroconvulsive therapy. Anesth Analg. 2003;96:1047–50.

    Article  PubMed  CAS  Google Scholar 

  9. Vishne T, Aronov S, Amiaz R, Etchin A, Grunhaus L. Remifentanil supplementation of propofol during electroconvulsive therapy: effect on seizure duration and cardiovascular stability. J ECT. 2005;21:235–8.

    Article  PubMed  Google Scholar 

  10. Claassen J, Hirsch LJ, Emerson RG, Mayer SA. Treatment of refractory status epilepticus with pentobarbital, propofol, or midazolam: a systematic review. Epilepsia. 2002;43:146–53.

    Article  PubMed  CAS  Google Scholar 

  11. Claassen J, Hirsch LJ, Mayer SA. Treatment of status epilepticus: a survey of neurologists. J Neurol Sci. 2003;211:37–41.

    Article  PubMed  Google Scholar 

  12. Smith M. Anesthetic agents and status epilepticus. Epilepsia. 2011;52(Suppl. 8):42–4.

    Article  PubMed  CAS  Google Scholar 

  13. Pruss H, Holtkamp M. Ketamine successfully terminates malignant status epilepticus. Epilepsy Res. 2008;82:219–22.

    Article  PubMed  Google Scholar 

  14. Kramer AH. Early ketamine to treat refractory status epilepticus. Neurocrit Care. 2012;16:299–305.

    Article  PubMed  Google Scholar 

  15. Mazarati AM, Wasterlain CG. N-methyl-d-aspartate receptor antagonists abolish the maintenance phase of self-sustaining status epilepticus in rat. Neurosci Lett. 1999;265:187–90.

    Article  PubMed  CAS  Google Scholar 

  16. Kapur J, Coulter DA. Experimental status epilepticus alters GABAA receptor function in CA1 pyramidal neurons. Ann Neurol. 1995;38:893–900.

    Article  PubMed  CAS  Google Scholar 

  17. Borris DJ, Bertram EH, Kapur J. Ketamine controls prolonged status epilepticus. Epilepsy Res. 2000;42:117–22.

    Article  PubMed  CAS  Google Scholar 

  18. Yeh PS, Shen HN, Chen TY. Oral ketamine controlled refractory nonconvulsive status epilepticus in an elderly patient. Seizure. 2011;20:723–6.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Section of Neurosurgery, Department of Surgery, University of Manitoba, Winnipeg, MB, Canada

    F. A. Zeiler, A. M. Kaufmann, M. West & J. Silvaggio

  2. Section of Critical Care Medicine, Department of Internal Medicine, University of Manitoba, Winnipeg, MB, Canada

    L. M. Gillman

Authors
  1. F. A. Zeiler
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. M. Kaufmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. L. M. Gillman
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. M. West
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. J. Silvaggio
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to F. A. Zeiler.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zeiler, F.A., Kaufmann, A.M., Gillman, L.M. et al. Ketamine for Medically Refractory Status Epilepticus After Elective Aneurysm Clipping. Neurocrit Care 19, 119–124 (2013). https://doi.org/10.1007/s12028-013-9858-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12028-013-9858-6

Keywords

Search

Navigation